文献速递儿童消化与营养儿童血液肿瘤与免疫

α1-抗胰蛋白酶缺乏症年轻患者纵向结局:新生儿胆汁淤积对未来门脉高压预测价值有限

Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal Hypertension.
PubMed 文献 · J Pediatr · 2020-07-11

本研究为前瞻性队列研究,纳入北美17个中心的350例0-25岁α1-抗胰蛋白酶缺乏症(AAT缺乏)原生肝脏患者,随访1077人年。门脉高压与身高Z评分降低相关。

要点

  • 新生儿胆汁淤积史对AAT缺乏患儿未来门脉高压预测价值弱。
  • 门脉高压与患儿身高Z评分降低相关。
  • AAT缺乏患儿肝移植进展缓慢、死亡罕见,但并发症风险持续存在。

核心结论

  • AAT缺乏青少年中门脉高压影响生长指标,新生儿胆汁淤积史是严重疾病的弱预测因素。

研究设计与样本

  • 前瞻性队列研究,纳入美国与加拿大17个三级中心的350例0-25岁PIZZ和PISZ型AAT缺乏原生肝脏患者,随访1077人年。

主要发现

  • 350例参与者中60%为男性,278例(79%)入组时无门脉高压,随访中18例发生门脉高压。
  • 门脉高压的发生与身高Z评分降低相关。

临床怎么用

  • 对AAT缺乏患儿应长期监测门脉高压及生长指标,即使无新生儿胆汁淤积史。
  • 新生儿胆汁淤积史不能作为预测未来严重肝病的可靠依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To identify predictors of portal hypertension, liver transplantation, and death in North American youth with alpha-1-antitrypsin (AAT) deficiency, and compare with patients with AAT deficiency elsewhere. STUDY DESIGN: The Childhood Liver Disease Research Network Longitudinal Observational Study of Genetic Causes of Intrahepatic Cholestasis is a prospective, cohort study of pediatric cholestatic liver diseases, including AAT deficiency, enrolling PIZZ and PISZ subjects 0-25 years of age seen since November 2007 at 17 tertiary care centers in the US and Canada. Data from standard-of-care baseline and annual follow-up visits were recorded from medical records, history, physical examination, and laboratory studies. Participants with portal hypertension were identified based on data collected. RESULTS: We enrolled 350 participants (60% male) with a native liver; 278 (79%) entered the cohort without portal hypertension and 18 developed portal hypertension during follow-up. Thirty participants required liver transplantation; 2 patients died during 1077 person-years of follow-up. There was no difference in participants with or without preceding neonatal cholestasis progressing to transplantation or death during the study (12% vs 7%; P = .09), or in experiencing portal hypertension (28% vs 21%; P = .16); the hazard ratio for neonatal cholestasis leading to portal hypertension was P = .04. Development of portal hypertension was associated with a reduced height Z-score. CONCLUSIONS: Portal hypertension in youth with AAT deficiency impacts growth measures. Progression to liver transplantation is slow and death is rare, but the risk of complications and severe liver disease progression persists throughout childhood. A history of neonatal cholestasis is a weak predictor of severe disease.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Teckman J, Rosenthal P, Hawthorne K, et al. Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal Hypertension. J Pediatr. 2020. PMID: 32663593. doi:10.1016/j.jpeds.2020.07.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。